Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 18 February 2005:
Vol. 307. no. 5712, p. 1025
DOI: 10.1126/science.307.5712.1025b
Prev | Table of Contents | Next

ScienceScope

The longtime acting head of the Food and Drug Administration (FDA) has been nominated for the agency's top post. Lester Crawford, a 66-year-old pharmacologist and veterinary medicine specialist, served as FDA's deputy commissioner during the brief tenure of Mark McClellan and has been acting commissioner since then. But some agency watchdogs have criticized his leadership. "We strongly oppose" his nomination, says Sidney Wolfe, director of the health research group Public Citizen in Washington, D.C., who cites Crawford's delays in removing the diet drug ephedra from the market and slapping warnings on the painkiller Vioxx.




ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)